Iron Triangle Partners LP Q3 2020 Filing

Filed November 16, 2020

Portfolio Value

$447.5M

Holdings

25

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (25 positions)

#StockSharesValue% PortfolioType
1
EHCENCOMPASS HEALTH CORP
697,659$45.3M10.13%
2
ZBHZIMMER BIOMET HOLDINGS INC
220,000$30.0M6.69%
3
CRLCHARLES RIV LABS INTL INC
130,000$29.4M6.58%
4
HZNPHORIZON THERAPEUTICS PUB L
350,000$27.2M6.08%
5
CTLTEURCATALENT INC
280,000$24.0M5.36%
6
HOLXHOLOGIC INC
357,833$23.8M5.32%
7
BSXBOSTON SCIENTIFIC CORP
600,000$22.9M5.12%
8
NVROEURNEVRO CORP
160,000$22.3M4.98%
9
IQVIQVIA HLDGS INC
140,000$22.1M4.93%
10
PACBPACIFIC BIOSCIENCES CALIF IN
2,000,000$19.7M4.41%
11
DVADAVITA INC
220,000$18.8M4.21%
12
GHGUARDANT HEALTH INC
166,000$18.6M4.15%
13
MOHMOLINA HEALTHCARE INC
100,000$18.3M4.09%
14
INOVALON HLDGS INC
650,000$17.2M3.84%
15
SGRYSURGERY PARTNERS INC
750,000$16.4M3.67%
16
ELVANTHEM INC
60,000$16.1M3.60%
17
AXNX*AXONICS MODULATION TECHNOLOG
303,201$15.5M3.46%
18
VCELVERICEL CORP
580,000$10.7M2.40%
19
BMYBRISTOL-MYERS SQUIBB CO
150,000$9.0M2.02%
20
INSPINSPIRE MED SYS INC
70,000$9.0M2.02%
21
TWSTTWIST BIOSCIENCE CORP
100,000$7.6M1.70%
22
OMGBPOUTSET MED INC
150,000$7.5M1.68%
23
NVSTENVISTA HOLDINGS CORPORATION
300,000$7.4M1.65%
24
BLFSBIOLIFE SOLUTIONS INC
150,000$4.3M0.97%
25
RPRXROYALTY PHARMA PLC
100,000$4.2M0.94%